Common Stock, Shares, Issued of Anixa Biosciences Inc from 31 Oct 2010 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Anixa Biosciences Inc quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Oct 2010 to 31 Jan 2026.
  • Anixa Biosciences Inc Common Stock, Shares, Issued for the quarter ending 31 Jan 2026 was 33,463,440, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,463,440 +1,266,578 +3.9% 31 Jan 2026 10-Q 09 Mar 2026 2026 Q1
Q3 2025 33,013,829 +816,967 +2.5% 31 Oct 2025 10-Q 09 Mar 2026 2026 Q1
Q2 2025 32,822,109 +675,649 +2.1% 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 32,211,092 +204,632 +0.64% 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 32,196,862 +442,487 +1.4% 31 Jan 2025 10-Q 11 Mar 2025 2025 Q1
Q3 2024 32,196,862 +1,051,643 +3.4% 31 Oct 2024 10-K 12 Jan 2026 2025 FY
Q2 2024 32,146,460 +1,128,690 +3.6% 31 Jul 2024 10-Q 06 Sep 2024 2024 Q3
Q1 2024 32,006,460 +1,047,795 +3.4% 30 Apr 2024 10-Q 04 Jun 2024 2024 Q2
Q4 2023 31,754,375 +831,545 +2.7% 31 Jan 2024 10-Q 12 Mar 2024 2024 Q1
Q3 2023 31,145,219 +231,317 +0.75% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q2 2023 31,017,770 +364,352 +1.2% 31 Jul 2023 10-Q 06 Sep 2023 2023 Q3
Q1 2023 30,958,665 +803,957 +2.7% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 30,922,830 +790,511 +2.6% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 30,913,902 +863,008 +2.9% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q2 2022 30,653,418 +703,513 +2.3% 31 Jul 2022 10-Q 09 Sep 2022 2022 Q3
Q1 2022 30,154,708 -1,295,197 -4.1% 30 Apr 2022 10-Q 10 Jun 2022 2022 Q2
Q4 2021 30,132,319 +3,953,197 +15% 31 Jan 2022 10-Q 11 Mar 2022 2022 Q1
Q3 2021 30,050,894 +5,802,199 +24% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q2 2021 29,949,905 +6,296,151 +27% 31 Jul 2021 10-Q 01 Sep 2021 2021 Q3
Q1 2021 31,449,905 +9,970,570 +46% 30 Apr 2021 10-Q 10 Jun 2021 2021 Q2
Q4 2020 26,179,122 +5,337,813 +26% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q1
Q3 2020 24,248,695 +3,916,941 +19% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q2 2020 23,653,754 +3,490,903 +17% 31 Jul 2020 10-Q 08 Sep 2020 2020 Q3
Q1 2020 21,479,335 +1,474,260 +7.4% 30 Apr 2020 10-Q 09 Jun 2020 2020 Q2
Q4 2019 20,841,309 +1,371,074 +7% 31 Jan 2020 10-Q 09 Mar 2020 2020 Q1
Q3 2019 20,331,754 +1,423,122 +7.5% 31 Oct 2019 10-K 07 Jan 2021 2020 FY
Q2 2019 20,162,851 +1,466,705 +7.8% 31 Jul 2019 10-Q 06 Sep 2019 2019 Q3
Q1 2019 20,005,075 +3,154,630 +19% 30 Apr 2019 10-Q 12 Jun 2019 2019 Q2
Q4 2018 19,470,235 +2,839,044 +17% 31 Jan 2019 10-Q 13 Mar 2019 2019 Q1
Q3 2018 18,908,632 +2,305,873 +14% 31 Oct 2018 10-K 09 Jan 2020 2019 FY
Q2 2018 18,696,146 +3,575,907 +24% 31 Jul 2018 10-Q 07 Sep 2018 2018 Q3
Q1 2018 16,850,445 +5,155,582 +44% 30 Apr 2018 10-Q 11 Jun 2018 2018 Q2
Q4 2017 16,631,191 +7,873,141 +90% 31 Jan 2018 10-Q 09 Mar 2018 2018 Q1
Q3 2017 16,602,759 +7,850,372 +90% 31 Oct 2017 10-K 11 Jan 2019 2018 FY
Q2 2017 15,120,239 +6,372,486 +73% 31 Jul 2017 10-Q 08 Sep 2017 2017 Q3
Q1 2017 11,694,863 +2,955,204 +34% 30 Apr 2017 10-Q 26 May 2017 2017 Q2
Q4 2016 8,758,050 +27,172 +0.31% 31 Jan 2017 10-Q 16 Mar 2017 2017 Q1
Q3 2016 8,752,387 +27,509 +0.32% 31 Oct 2016 10-K 09 Jan 2018 2017 FY
Q2 2016 8,747,753 +26,875 +0.31% 31 Jul 2016 10-Q 19 Aug 2016 2016 Q3
Q1 2016 8,739,659 -210,192,531 -96% 30 Apr 2016 10-Q 20 May 2016 2016 Q2
Q4 2015 8,730,878 -210,981,312 -96% 31 Jan 2016 10-Q 19 Feb 2016 2016 Q1
Q3 2015 8,724,878 -63,298 -0.72% 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q2 2015 8,720,878 -228,101,312 -96% 31 Jul 2015 10-Q 18 Aug 2015 2015 Q3
Q1 2015 218,932,190 -490,000 -0.22% 30 Apr 2015 10-Q 22 May 2015 2015 Q2
Q4 2014 219,712,190 +9,194,660 +4.4% 31 Jan 2015 10-Q 09 Mar 2015 2015 Q1
Q3 2014 8,788,176 -200,488,569 -96% 31 Oct 2014 10-K 23 Dec 2015 2015 FY
Q2 2014 236,822,190 +30,646,001 +15% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 219,422,190 +19,532,394 +9.8% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 210,517,530 +25,413,493 +14% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 209,276,745 +24,297,708 +13% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 206,176,189 +21,986,402 +12% 31 Jul 2013 10-Q/A 20 Sep 2013 2013 Q3
Q1 2013 199,889,796 +18,425,149 +10% 30 Apr 2013 10-Q/A 19 Jun 2013 2013 Q2
Q4 2012 185,104,037 +4,648,900 +2.6% 31 Jan 2013 10-Q/A 25 Mar 2013 2013 Q1
Q3 2012 184,979,037 +8,847,990 +5% 31 Oct 2012 10-K/A 17 Jan 2014 2013 FY
Q2 2012 184,189,787 +12,033,480 +7% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 181,464,647 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 180,455,137 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 176,131,047 +22,386,609 +15% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 172,156,307 31 Jul 2011 10-Q/A 14 Oct 2011 2011 Q3
Q3 2010 153,744,438 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.